✦ LIBER ✦

Comparison of two dosing regimens of gabexate in the prophylaxis of post-ERCP pancreatitis

✍ Scribed by Enzo Masci; Giorgio Cavallini; Alberto Mariani; Luca Frulloni; Pier Alberto Testoni; Simona Curioni; Alberto Tittobello; Generoso Uomo; Guido Costamagna; Sandro Zambelli; Gianpiero Macarri; Paolo Innocenti; Carola Dragonetti

Book ID: 119394316
Publisher: Nature Publishing Group
Year: 2003
Tongue: English
Weight: 60 KB
Volume: 98
Category: Article
ISSN: 0002-9270
DOI: 10.1016/s0002-9270(03)00704-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Prophylaxis of post-ERCP pancreatic comp

Prophylaxis of post-ERCP pancreatic complications with gabexate

✍ F. Piscaglia; R. Righini; A.G. Tewelde 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 45 KB

Comparison of two dosing regimens of gab

Comparison of two dosing regimens of gabexate mesilate (FOY® in the prevention of post-ercp pancreatitis: Results of a multicentre controlled trial

✍ A. Mariani; L. Frulloni; E. Masci; S. Curioni; A. Tittobello; G. Cavallini 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 153 KB

High dose of octreotide as a prophylaxis

High dose of octreotide as a prophylaxis of post-ERCP pancreatitis

✍ Angelo Andriulli 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 54 KB

Efficacy of postprocedure administration

Efficacy of postprocedure administration of gabexate mesylate in the prevention of post-ERCP pancreatitis: a randomized, controlled, multicenter study

✍ Gianpiero Manes; Sandro Ardizzone; Giovanni Lombardi; Generoso Uomo; Oreste Pier 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 189 KB

Nafamostat mesylate in the prevention of

Nafamostat mesylate in the prevention of post-ERCP pancreatitis and risk factors for post-ERCP pancreatitis

✍ Cheol Woong Choi; Dae Hwan Kang; Gwang Ha Kim; Jae Sup Eum; Sun Mi Lee; Geun Am 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 236 KB

Frequency of post-ERCP pancreatitis in a

Frequency of post-ERCP pancreatitis in a single tertiary referral centre without and with routine prophylaxis with gabexate: A 6-year survey and cost-effectiveness analysis

✍ P.A. Testoni; A. Mariani; E. Masci; S. Curioni 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 112 KB